Literature DB >> 12847486

The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation.

Akinori Mochizuki1, Alan R McEuen, Mark G Buckley, Andrew F Walls.   

Abstract

BACKGROUND: Basogranulin, the novel basophil granule protein recognized by the monoclonal antibody BB1, can be released by stimulation with anti-IgE antibody or calcium ionophore. However, the kinetics and regulation of its secretion are unknown.
OBJECTIVE: We quantified basogranulin and histamine release in response to a range of stimuli to assess whether basogranulin secretion is a reliable marker of basophil activation.
METHODS: Isolated peripheral blood basophils were stimulated with anti-IgE antibody, calcium ionophore, N -formyl-Met-Leu-Phe, and complement C5a. The released basogranulin and histamine were quantified by dot blotting with BB1 and a fluorometric method, respectively. Basogranulin localization was confirmed by flow cytometry.
RESULTS: Both basogranulin and histamine displayed a bell-shaped response curve when basophils were challenged with anti-IgE. Half-maximal release occurred within 30 seconds. Basogranulin levels were maximal by 15 minutes, whereas those for histamine continued increasing to 30 minutes. Wortmannin, a PI3-K inhibitor, suppressed the release of both mediators. Basophils from donors with the "nonreleaser" phenotype secreted neither mediator in response to anti-IgE. Non-IgE-dependent stimuli released both mediators in parallel in a concentration-dependent manner. The correlation between the relative amounts of each mediator released was highly significant (r =.901, P <.0001, n = 87). Flow cytometry revealed that some of the secreted basogranulin adhered to the cell surface.
CONCLUSIONS: Basogranulin is secreted along with histamine in response to both FcepsilonR I-related and unrelated stimuli. It is therefore a valid marker of basophil activation and could provide the basis for an immunoassay that distinguishes between basophil and mast cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847486     DOI: 10.1067/mai.2003.1511

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 2.  Response to Ebo et al., Letter to the Editor Regarding Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-04       Impact factor: 4.806

3.  Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects.

Authors:  F Runa Ali; A Barry Kay; Mark Larché
Journal:  Thorax       Date:  2007-03-27       Impact factor: 9.139

4.  Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma.

Authors:  Chun Kwok Wong; Ting Fan Leung; Ida Miu Ting Chu; Jie Dong; Yvonne Yi On Lam; Christopher Wai Kei Lam
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 5.  Emerging role of human basophil biology in health and disease.

Authors:  Jessica L Cromheecke; Kathleen T Nguyen; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 6.  Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives.

Authors:  Sarah C Beck; Thomas Wilding; Richard J Buka; Richard L Baretto; Aarnoud P Huissoon; Mamidipudi T Krishna
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 7.  Behind the scenes with basophils: an emerging therapeutic target.

Authors:  Hemali Shah; Stephanie Eisenbarth; Christopher A Tormey; Alexa J Siddon
Journal:  Immunother Adv       Date:  2021-05-19

8.  Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils.

Authors:  Anm Nazmul H Khan; Tiffany R Emmons; Jerry T Wong; Emad Alqassim; Kelly L Singel; Jaron Mark; Brandon E Smith; Joseph D Tario; Kevin H Eng; Kirsten B Moysich; Kunle Odunsi; Scott I Abrams; Brahm H Segal
Journal:  Cancer Immunol Res       Date:  2020-04-01       Impact factor: 12.020

9.  Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole.

Authors:  Adriana Ariza; Elena García-Martín; María Salas; María I Montañez; Cristobalina Mayorga; Natalia Blanca-Lopez; Inmaculada Andreu; James Perkins; Miguel Blanca; José A G Agúndez; María J Torres
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

Review 10.  Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Authors:  Dean D Metcalfe; Ruby Pawankar; Steven J Ackerman; Cem Akin; Frederic Clayton; Franco H Falcone; Gerald J Gleich; Anne-Marie Irani; Mats W Johansson; Amy D Klion; Kristin M Leiferman; Francesca Levi-Schaffer; Gunnar Nilsson; Yoshimichi Okayama; Calman Prussin; John T Schroeder; Lawrence B Schwartz; Hans-Uwe Simon; Andrew F Walls; Massimo Triggiani
Journal:  World Allergy Organ J       Date:  2016-02-11       Impact factor: 4.084

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.